Printer Friendly

ANGEION NAMES EMPI FOUNDER & CEO TO BOARD

 ANGEION NAMES EMPI FOUNDER & CEO TO BOARD
 MINNEAPOLIS/ST.PAUL, Feb. 20 /PRNewswire/ -- Angeion Corporation


(NASDAQ: ANGN) has named Donald D. Maurer to its board of directors. This appointment expands Angeion's Board of Directors from seven to eight members.
 Maurer is a businessman and scientist. He is the founder, chairman and CEO of Empi, Inc., a medical manufacturer of noninvasive biomedical devices and accessories for electrotherapeutic applications. Maurer founded Empi in 1977 and was elected chairman of the board of Empi, Inc. in 1978. He joined Empi as president and CEO in 1979.
 Prior to joining Empi, Maurer was founding director of the rehabilitation engineering program at the Courage Center, a nonprofit institute for the severely disabled, where he developed a variety of devices to aid in the daily living of the handicapped.
 From 1966 to 1977, Maurer served in various capacities at Medtronic, Inc. culminating in the position of director of functional stimulation research. At Medtronic, Maurer developed new concepts in neurostimulation and numerous devices for the control of pain and neuromuscular function.
 Maurer began he career in 1960 at Univac, and has also worked at Control Data. He has a degree in communications technology, a bachelor of science degree in electrical engineering and a master of science degree in biomedical engineering.
 Maurer holds 17 patents on biomedical devices, is the author of numerous published papers in the field of neuroelectric research and is a frequent speaker at seminars on medical devices.
 Minneapolis-based Angeion Corporation is a manufacturer of interventional accessories primarily for the cardiovascular markets. Angeion's subsidiaries, AngeMed, Inc. and AngeLase, Inc., are developing products for the treatment of various types of arrhythmias. In addition to its listing on NASDAQ, Angeion is also listed on the Boston Stock Exchange under the symbol ANI.
 -0- 2/20/92
 /CONTACT: Brenda Roth of Angeion, 612-550-9388/
 (ANGN ANI) CO: Angeion Corporation ST: Minnesota IN: MTC SU: PER


AL -- MN008 -- 0969 02/20/92 13:27 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 20, 1992
Words:325
Previous Article:JOVAN MUSK COMMERCIAL BANNED BY NETWORK CENSORS
Next Article:OGDEN'S W.J. SCHAFER UNIT WINS $100 MILLION SDIO CONTRACT TO RESEARCH HIGH ENERGY LASERS
Topics:


Related Articles
ANGEION ANNOUNCES NEW CHAIRMAN & CEO
ANGEION NAMES VP OF OPERATIONS
EMPI, INC., NAMES JOSEPH E. LAPTEWICZ JR. PRESIDENT AND CHIEF EXECUTIVE OFFICER
EMPI NAMES GARY D. SULLIVAN VICE PRESIDENT, MARKETING
ANGEION REORGANIZES FOR EXPANDING OPERATIONS
ANGEION VICE PRESIDENT RESIGNS
FORMER EMPI, MEDTRONIC REGULATORY PERSON JOINS ANGEION AS VICE PRESIDENT, REGULATORY AND CLINICAL AFFAIRS
ANGEION HIRES VICE PRESIDENT OF MARKETING AND SALES AND VICE PRESIDENT OF HUMAN RESOURCES
ANGEION HIRES V.P. OF RESEARCH
ANGEION NAMES EMPI FOUNDER AND CEO TO BOARD

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters